Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03604432 · ClinicalTrials.gov registry record · NA

Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery

A NA study of Coronary Artery Disease, sponsored by Corewell Health West.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT03604432 is a NA study of Coronary Artery Disease that has completed, run by Corewell Health West. The registered enrollment target is 60 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03604432, a NA study of Coronary Artery Disease, has completed, sponsored by Corewell Health West.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will look at performing a prophylactic limited left sided maze procedure during concomitant adult cardiac surgery to prevent the common occurrence of postoperative atrial fibrillation.

Conditions Studied

Interventions

  • DEVICE propylactic maze

Study Locations (1)

Michigan

  • Spectrum Health Hospitals - Grand Rapids

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2020-02-01
Est. Completion 2023-02-10
Phase NA

Sponsor

Corewell Health West

38 total trials

What the Registry Record Tells You About NCT03604432

The ClinicalTrials.gov registry entry for NCT03604432 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower). The listed sponsor is Corewell Health West, which has 38 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which propylactic maze is the first listed.

NCT03604432 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT03604432 about?

NCT03604432 is a clinical study titled "Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery". This study will look at performing a prophylactic limited left sided maze procedure during concomitant adult cardiac surgery to prevent the common occurrence of postoperative atrial fibrillation.

What is the current status of trial NCT03604432?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2020-02-01. Estimated completion is 2023-02-10.

What conditions does trial NCT03604432 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT03604432?

The interventions under investigation include: propylactic maze (DEVICE).

Who is sponsoring clinical trial NCT03604432?

This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03604432 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.